NBGI Ventures
19
18M
13
0.95
3
0.32
8
- Stages of investment
- Areas of investment
Summary
NBGI Ventures is the famous VC, which was founded in 2001. The main office of represented VC is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the NBGI Ventures, startups are often financed by Telegraph Hill Partners, Omnes Capital, Bioam Gestion. The meaningful sponsors for the fund in investment in the same round are Omnes Capital, Auriga Partners, Andera Partners. In the next rounds fund is usually obtained by Wellington Partners, Omnes Capital, Auriga Partners.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight EOS Imaging, EPIX Therapeutics, Quanta. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Manufacturing. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager.
The current fund was established by Aris Constantinides, Spiros Trachanis.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2017. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this NBGI Ventures works on 15 percentage points more the average amount of lead investments. The top activity for fund was in 2010.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 3
- Exits
- 8
- Rounds per year
- 0.95
- Follow on index
- 0.32
- Investments by industry
- Health Care (14)
- Medical Device (13)
- Biotechnology (11)
- Manufacturing (9)
- Medical (5) Show 11 more
- Investments by region
-
- France (6)
- United Kingdom (4)
- United States (5)
- Switzerland (1)
- Sweden (1) Show 2 more
- Peak activity year
- 2010
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 165M
- Group Appearance index
- 0.95
- Avg. company exit year
- 13
- Avg. multiplicator
- 11.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
CellNovo | 04 Feb 2011 | Biotechnology, Health Care, Medical Device, Diabetes | Early Stage Venture | 41M | England, Allerdale, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.